Used in pharmaceutical synthesis as a key intermediate for developing biologically active compounds, particularly in the production of kinase inhibitors and central nervous system agents. Its fluorinated aryl structure enhances binding selectivity and metabolic stability in drug candidates. Commonly employed in medicinal chemistry for structure-activity relationship (SAR) studies due to the cyclopropyl group’s conformational restraint and the fluorine atom’s electronic effects. Also utilized in the development of radiolabeled derivatives for positron emission tomography (PET) imaging probes.